1. R. W. Brimblecombe, W. A. M. Duncan, G. J. Durant, J. C. Emmett, C. R. Ganellin and M. E. Parsons,Cimetidine—a non-thiourea H2-receptorantagonist. J. int. Med. Res.3, 86–92 (1975).
2. M. J. Daly, J. M. Humphray and R. Stables,Some in vitro and in vivo actions of the new histamine H 2-receptor antagonists, ranitidine, Br. J. Pharmac.72, 49–54 (1981).
3. R. T. Brittain and D. Jack,Histamine H 2-antagonists: past, present and future. InReceptors and the Upper G.I. tract (Ed. B. I. Hirschowitz and J. G. Spenney) Advanced Therapeutics Communications Inc., New York 1983.
4. M. L. Torchiana, R. G. Pendleton, P. G. Cook, C. A. Hanson and B. L. Clineschmidt,Apparent irreversible H 2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidino-methyl)phenoxy] propyl)amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643,441), J. Pharmac. Exp. Ther.224, 514–519 (1983).
5. R. G. Pendleton, M. L. Torchiana, C. Chung, P. Cook, S. Wiese and B. L. Clineschmidt,Studies of MK-208 (YM-11170) a new, slowly dissociable H 2-receptor antagonists. Arch. Int Pharmacodyn.266, 4–16 (1983).